Navigation Links
Mach One CEO Letter to Shareholders

BELGIUM, Wis., April 15 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces Monte B. Tobin, the President and CEO, has released the following letter to Mach One's shareholders:

Dear Fellow Shareholders:

The mission of Mach One Corporation is to seek, acquire and develop innovative global wellness organizations that provide bio-based solutions to help address one of the world's most pressing and costly needs -- positive, long-term health and longevity benefits for animals and humans. While animal wellness, organic and sustainable products are our initial, primary focus, we intend in the near future to add Nutraceuticals to our growing list of ventures. In the process, we intend to be agile and swift in spotting business opportunities and respective businesses to expand our vision for positive contribution to global wellness.

During 2008, Mach One Corporation began a process of gathering promising enterprises, biotechnologies, expertise and funding into a single organization that can address the needs of global wellness in a time of new threats and challenges. In January 2009, we closed a $1.5 million capital raise and a Subordinated Note Swap of $1.5 million to help Mach One expand our acquisition growth strategy, as well as enhance internal growth of our Bridge (TM) product suite.

During the first quarter of 2009, Mach One Corporation announced three significant additions: (1) Pacific Rim Foods Ltd., a multinational holding company with interests in energy, oil, and food production; (2) Ceres Organic Harvest, Inc. which along with its subsidiary, Organic Grain and Milling, Inc., supplies organic grain and grain-based ingredients to the food, feed and dairy industries; and (3) Modular Process Constructors, LLC (recently renamed MPS-BioPharm) that engages in the design and manufacture of constructed systems for the biopharmaceutical industry.

Today Mach One and its three operating groups: Animal Wellness, Organics and Sustainables, and BioPharm Process Systems offer a broad range of solutions to global health problems, from helping calves develop immunity at birth to carefully managing organic grain crops to testing equipment that helps detect compromised food products long before they can cause a problem.

In addition, Mach One's management team has been expanded and strengthened. New to the Board of Directors are Tad Ballantyne, CEO and President Pacific Rim Foods, and Brittin Eustis, CEO and President of Ceres Organic Harvest, now Mach One Organics and Sustainables Group. Also new to the Mach One Organics and Sustainables Group are Troy DeSmet, Vice President, Director of Grain Procurement and Dean Chapla, Vice President, Corporate Counsel and Director of Elevator Operations. Joining from MPS-BioPharm are Rick Kramer and Stephen Hynds as Chief Operating Officer and Chief Sales and Marketing Officer, respectively. Most recently, Pat Sheridan, a CPA and experienced financial executive, was appointed to serve as Mach One's Chief Financial Officer. With these seasoned executives in place we are now better positioned to pursue our mission.

In a global village, where the health of our food supply and ourselves is vulnerable to the rapid spread of new and old threats, our vision at Mach One is to play a major role in sustaining wellness. At Mach One, we are committed to delivering solutions that positively impact global wellness -- through application of biotechnology to enhance the defensive capabilities of both animal and human immune systems.

I intend to put out letters such as this throughout the year to keep you updated on our progress and to report events that are happening within Mach One. I also encourage you to look at our newly revamped website at The re-designed and expanded web site reflects our growth as a company and the recent expansion of our products and services. The new, robust site will allow shareholders and customers to review the news and events from each our operating groups as well as the latest as to our progress.

I want to thank all of our dedicated employees and loyal shareholders and I look forward to your continued support and a prosperous 2009.


Monte B. Tobin, Chairman and Chief Executive Officer

About Mach One Corporation:

Mach One Corporation ( is a global wellness company that provides biotechnology based solutions to help address one of the world's most pressing and costly needs -- positive, long-term health and longevity benefits for humans and disease-threatened animals of commercial operations. While animal wellness, organic and sustainable products are our initial primary focus, we intend in the near future to add Nutraceuticals to our growing list of operating groups. As an ongoing objective we intend to be agile and swift in spotting business opportunities and respective businesses to expand our vision for positive contribution to global wellness.

Mach One strongly encourages the public to read the above information in conjunction with its Form 10-K for December 31, 2008. Mach One's disclosures can be viewed at and

Cautionary Statement: This news release may include certain "Forward-looking statements" within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release.

SOURCE Mach One Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing partnership between the ... has been formalized with the signing of a Memorandum of Understanding. , AMA ... Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) ... research organisation (CRO) market. The trend of outsourcing ... lower margins but higher volume share for the ... and scale, however, margins in the CRO industry ... (CRO) Market ( ), finds that ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology:
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):